{
  "chapter": "Virology-Picornaviridae And Rhabdoviridae",
  "questions": [
    {
      "q_no": 1,
      "question": "During an outbreak investigation in a labor colony, health officials are tracking a viral infection. The causative virus has these characteristics: exclusively human reservoir, fecal-oral transmission, and three distinct serotypes. The outbreak is showing these features: predominantly affects unvaccinated children, begins with fever and headache, and in some cases progresses to acute flaccid paralysis. The investigation team is discussing viral characteristics. Which of the following statements about this virus is INCORRECT?",
      "options": {
        "A": "Virus can be isolated from feces for up to 6 weeks after symptom onset",
        "B": "Type 2 commonly causes endemic infections",
        "C": "Type 1 is the least common cause of epidemics",
        "D": "Virus shedding begins 2 days before symptom onset"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Type 1 is the least common cause of epidemics Explanation: Type 1 poliovirus is the most common and causes most epidemics . Poliovirus Types and Strains Type 1 (Brunhilde, Mahoney): Most common, causes epidemics Type 2 (Lansing, MEF1): Endemic infections (Option B) Type 3 (Leon, Saukett): Can cause epidemics Viral Antigens D antigen: Found in whole virion, type-specific, protective C antigen: Found in empty virus, not protective No common group antigen Heat converts D to C antigen (56°C) Transmission Factors Route: Primarily fecal-oral Source: Human feces, throat secretions Reservoir: Only humans Environmental survival: 6 months in sewage Resistant to: pH 3, ether, detergents Time Course Incubation: Range 4-28 days (average 10) Communicable period: -2 to +5 days from symptoms Fecal shedding: Up to 6 weeks (Option A) Initial symptoms: 1-5 days Asymptomatic period: 2-3 days Major illness onset: 3-4 days after minor illness Clinical-Epidemiological Aspects Subclinical:Clinical = 1000:1 or 100:1 Risk enhancers: Pregnancy, tonsillectomy, injections Cross-immunity: Between 1&2, 2&3; minimal 1&3 Peak season: Late winter and early spring No carrier state exists Viral shedding in feces continues for several weeks: 80% in first week, 50% till third week, 25% till sixth week ( Option A) Type 2 typically causes endemic infections rather than epidemics ( Option B) Infectivity begins 2 days before symptom onset and continues until 5 days after ( Option D) Reference: Ananthnarayan & Paniker’s Textbook of Microbiology, 10th Edition, Page 491-497",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 2,
      "question": "A 4-year-old unvaccinated child presents with a biphasic illness. The initial phase included fever, headache, and sore throat lasting 5 days, followed by 2 days of improvement. Now the child has returned with high fever, neck stiffness, and weakness in the right leg. The CSF analysis shows aseptic meningitis. About the pathogenesis of this viral infection, which of the following sequences is correct? → Viremia → CNS symptoms → Muscular weakness → RES (reticuloendothelial system) multiplication → Secondary viremia → CNS invasion → Anterior horn cell destruction → Direct neural spread → CNS invasion → Secondary viremia → Direct CNS invasion → Muscular weakness → Secondary viremia",
      "options": {
        "A": "Direct neural invasion",
        "B": "Primary viremia",
        "C": "Respiratory infection",
        "D": "Primary viremia"
      },
      "correct_answer": "B",
      "explanation": "→ RES (reticuloendothelial system) multiplication → Secondary viremia → CNS invasion → Anterior horn cell destruction Correct Answer: B) Primary viremia → RES multiplication → Secondary viremia → CNS invasion → Anterior horn cell destruction Explanation: The clinical presentation is indicative of Poliomyelitis . The correct sequence of pathogenesis of Poliomyelitis is represented below, which follows the virus's natural progression: Virus enters orally and causes primary viremia Multiplies in reticuloendothelial system (RES) Causes secondary viremia Invades CNS Destroys anterior horn cells, leading to paralysis Poliomyelitis- Pathogenesis and Clinical Features Pathogenesis Stages 1. Entry: Oral route 2. Initial replication: Nasopharynx and GI tract 3. Primary viremia: Virus enters bloodstream 4. RES multiplication: In lymphoid tissues 5. Secondary viremia: More extensive spread 6. CNS invasion: Via bloodstream or neural route 7. Anterior horn cell destruction: Causes paralysis Clinical Presentations Inapparent Infection (90-95%): - Asymptomatic - Only seroconversion Abortive Poliomyelitis (4-8%): - Fever - Headache - Sore throat - Malaise - Duration: 1-5 days Non-paralytic (1-2%): - Aseptic meningitis - Stiff neck - Spinal rigidity Paralytic (0.1-1%): - Asymmetric paralysis - Muscle weakness - Respiratory involvement possible CNS Changes Chromatolysis of Nissl bodies Nuclear degeneration Cell lysis Inflammatory response Anterior horn predominantly affected Recovery Patterns Recovery begins: 2-3 weeks after paralysis Maximum recovery: Within 6 months Residual paralysis: May persist Death rate: 5-10% (respiratory involvement) Muscle atrophy: Common in affected limbs Reference: Ananthnarayan & Paniker’s Textbook of Microbiology 10th Edition Page 491-497",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 3,
      "question": "A 5-year-old child presents to the clinic with fever, headache, and neck stiffness. Two days later, he developed weakness in his left leg, with loss of reflexes but no sensation changes. A cerebrospinal fluid (CSF) analysis shows mild pleocytosis and a slight increase in protein levels. What is the most likely diagnosis, and which test should be done first?",
      "options": {
        "A": "Guillain-Barré Syndrome; perform nerve conduction studies.",
        "B": "Nonparalytic poliovirus infection; obtain a throat swab for viral PCR.",
        "C": "Viral meningitis; order a PCR for enterovirus on CSF.",
        "D": "Paralytic poliomyelitis; obtain stool and throat samples for poliovirus PCR."
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Paralytic poliomyelitis; obtain stool and throat samples for poliovirus PCR. loss of reflexes without sensory loss . Testing for poliovirus in stool and throat samples is preferred, as poliovirus can often be isolated early in the illness. In this child’s case, the asymmetric limb weakness and reflex loss, coupled with the mild CSF findings, align most closely with paralytic polio. Clinical manifestations of Poliovirus Asymptomatic (70%): No symptoms, immunity develops silently. Abortive Poliomyelitis (24%): Minor flu-like symptoms (fever, sore throat, headache) lasting 1–2 days. Nonparalytic Aseptic Meningitis (1–5%): Headache, neck stiffness, and muscle pain lasting 2–10 days. Paralytic Poliomyelitis (0.1–0.5%): Spinal : Limb paralysis. Bulbar : Difficulty breathing, and swallowing. Bulbospinal : Combination of both. Often asymmetrical muscle weakness and loss of reflexes, with respiratory failure in severe cases. Post-Polio Syndrome : Progressive muscle weakness and fatigue years after initial infection. Diagnosis Clinical Examination : Neurological assessment for muscle weakness and paralysis. Laboratory Testing : Stool/Throat Samples : Virus isolation. CSF Analysis : Detects inflammation. PCR : Detects poliovirus RNA. Serology : Identifies antibodies if virus isolation is unsuccessful. Imaging (MRI) : For severe cases to assess nerve involvement. Vaccination Two types of vaccines are available. OPV (Sabin) IPV (Salk) Type Live attenuated virus Killed formalised virus Route Oral ID (preferred) or SC or IM Dose 2 drops or as stated on the label Intradermally, 0.1ml (fractional IPV or fIPV) Schedule 1st dose: 6 weeks 2nd dose: 10 weeks 3rd dose: 14 weeks Booster dose: 16-24 months 1st dose: 6 weeks 2nd dose: 14 weeks 3rd dose: 9 completed months Immunity provided Humoral + Intestinal Humoral Prevents Paralysis Intestinal re-infection Paralysis Storage & transport Requires sub-zero temperatures Less stringent conditions Shelf life Short Longer Guillain-Barré Syndrome; perform nerve conduction studies (Option A) , is incorrect as while Guillain-Barré also causes weakness and loss of reflexes, it is typically symmetric (both sides of the body are affected equally) and often follows a respiratory or gastrointestinal illness. Diagnosis involves nerve conduction studies and lumbar puncture for CSF analysis, but this child’s symptoms and asymmetry make polio more likely. Nonparalytic poliovirus infection; obtaining a throat swab for viral PCR (Option B) is incorrect as paralytic polio causes fever, headache, and neck stiffness without progressing to muscle weakness. A PCR for polio in throat swabs is correct, but this doesn’t fully explain the new weakness. Viral meningitis; order a PCR for enterovirus on CSF (Option C) , is incorrect as viral meningitis often presents with fever, headache, and neck stiffness, and enterovirus is a common cause. However, it does not typically cause focal (one-sided) muscle weakness or reflex loss.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 4,
      "question": "You’re seeing a 6-year-old patient who’s had a fever, sore throat, and painful sores in the mouth for the past few days. He now has small red spots and blisters on his palms and soles. During the exam, as shown, you notice vesicles on the soft palate and pinkish lesions on his hands and feet. Given these symptoms, what’s the most likely diagnosis and causative agent?",
      "options": {
        "A": "Coxsackie B; Pleurodynia",
        "B": "Coxsackie A; Hand, Foot, and Mouth Disease",
        "C": "Coxsackie A; Herpangina",
        "D": "Coxsackie B; Hand, Foot, and Mouth Disease"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Coxsackie A; Hand, Foot, and Mouth Disease Explanation: With this child’s fever, mouth sores, and characteristic rash on the hands and feet, Hand, Foot, and Mouth Disease caused by Coxsackie A is the most fitting answer. Hand-foot-and-mouth disease is a vesicular exanthem usually caused by coxsackievirus A16. The name is descriptive because the main features of this infection consist of vesicular lesions on the hands, feet, mouth, and tongue . The patient is mildly febrile , and the illness subsides in a few days. Coxsackie virus: Types and clinical manifestations Coxsackie Virus Type Associated Conditions Clinical Manifestations Coxsackie A Primarily skin and mucosal infections Hand, Foot, and Mouth Disease (HFMD) : Fever, painful red spots/blisters on hands, feet, and inside the mouth; may spread to elbows, knees, or buttocks. (Option B) (Option D ruled out) Herpangina : Sudden high fever, painful ulcers/vesicles on soft palate, uvula, and tonsils; sore throat, headache, difficulty swallowing. (Option C ruled out) Coxsackie B Primarily systemic infections Pleurodynia (Bornholm Disease) : Sudden, severe, stabbing chest or abdominal pain; intermittent, lasting days, with fever and muscle tenderness. (Option A ruled out) Myocarditis and Pericarditis : Chest pain, fatigue, palpitations, irregular heartbeat; severe cases may lead to heart failure. Pancreatitis (rare): Inflammation of",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmicrobiology/Virology-Picornaviridae_And_Rhabdoviridae_Q4_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 5,
      "question": "A 2-year-old child presents with fever, headache, and neck stiffness. A physical exam shows a mild skin rash, but no other remarkable findings. Cerebrospinal fluid (CSF) analysis suggests aseptic meningitis. Which of the following is the most likely causative agent, and what is another common manifestation associated with this virus type?",
      "options": {
        "A": "Enterovirus; Acute Flaccid Myelitis (AFM)",
        "B": "Coxsackie B virus; Hand, Foot, and Mouth Disease (HFMD)",
        "C": "ECHO virus; Upper Respiratory Infections",
        "D": "Poliovirus; Myocarditis"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) ECHO virus; Upper Respiratory Infections Explanation: ECHO virus is a frequent cause of aseptic meningitis , particularly in children. It can also cause mild skin rashes, respiratory infections , and other less severe symptoms, making this the best answer for the presentation described. Enterovirus and ECHO virus : Virus Transmission Common Infections Severe Manifestations Enterovirus Fecal-oral, respiratory Hand, Foot, and Mouth Disease (HFMD) : Usually caused by Enterovirus A (e.g., EV-A71). Aseptic Meningitis : Fever, headache, neck stiffness, photophobia; multiple Enterovirus types. Herpangina : Sudden fever, painful throat ulcers; Enterovirus A. Acute Hemorrhagic Conjunctivitis : Red eyes with hemorrhage; Enterovirus D. Myocarditis and Pericarditis : Heart inflammation, and chest pain, caused by Enterovirus B. Acute Flaccid Myelitis (AFM) : Neurological condition causing limb weakness, often Enterovirus D68. Neonatal Sepsis-like Illness : Severe illness in newborns, fever, irritability, potential organ failure. ECHO Virus Fecal-oral Aseptic Meningitis : Fever, headache, neck stiffness; most common ECHO virus manifestation. Exanthems : Non-specific rashes, often in children. Upper Respiratory Infections : Cough, sore throat, mild fever. Gastroenteritis : Vomiting, diarrhea, abdominal pain. Myocarditis and Pericarditis : Can lead to chest pain, and palpitations. Neonatal Infections : Severe in newborns, presenting as sepsis-like illness or hepatitis. Enterovirus; Acute Flaccid Myelitis (Option A) is incorrect. While Enterovirus (especially EV-D68) can cause AFM, this rare and severe presentation is not as common in the age group described and is usually associated with paralysis rather than a mild rash and meningitis. Coxsackie B virus; HFMD (Option B), is incorrect as Coxsackie B is known for causing myocarditis and pericarditis , not HFMD , which is typically associated with Coxsackie A. HFMD also commonly presents with mouth sores, which are not seen here. Poliovirus; Myocarditis (Option D) is incorrect as Poliovirus can cause flaccid paralysis but is not known to cause myocarditis. Additionally, polio is now rare due to vaccination and does not fit the presentation of fever with aseptic meningitis. Reference: Medical Microbiology by Patrick R. Murray, 8th Edition, Pages 461 and 465.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 6,
      "question": "A 25-year-old patient with a history of asthma comes to your clinic with complaints of a runny nose, sore throat, mild cough, and a low-grade fever that started a few days ago. On examination, you note nasal congestion but no wheezing or serious respiratory distress. Which of the following is the most likely cause of his symptoms, and what’s the underlying mechanism? and fever.",
      "options": {
        "A": "Rhinovirus infection, attaching to ICAM-1 receptors in the nasal lining and triggering inflammation.",
        "B": "Influenza virus infection causes a systemic cytokine storm by binding to respiratory epithelial cells.",
        "C": "Adenovirus infection binds to lower respiratory tract cells, leading to cell damage and high fever.",
        "D": "Streptococcus pneumoniae infection colonizes the throat and releases toxins that cause severe pain"
      },
      "correct_answer": "A",
      "explanation": "triggering inflammation. Correct Answer: A) Rhinovirus infection, attaching to ICAM-1 receptors in the nasal lining and triggering inflammation. Explanation: Rhinovirus, a common cold culprit, binds to ICAM-1 receptors in the upper respiratory tract , particularly in the nose. This process triggers cytokines , which cause congestion, a sore throat, and mild fever . His asthma might make him a little more sensitive, but rhinovirus usually stays in the upper airways, rarely moving deeper. Rhinovirus classification : Family Picornaviridae, over 100 serotypes in three species (A, B, and C), with type C often causing more severe symptoms. Pathogenesis: Transmission : Spread by respiratory droplets and contact with contaminated surfaces. Attachment : Binds to ICAM-1 receptors on upper respiratory epithelial cells, where it replicates, causing cell damage. Immune Response : Infected cells release cytokines, causing inflammation and typical cold symptoms. Temperature Sensitivity : Thrives at 33-35°C, usually limited to the upper respiratory tract. Clinical Manifestations: Common Cold : Runny nose, congestion, sneezing, sore throat, cough, headache, lasting about 7-10 days. Exacerbation of Asthma and COPD : Can worsen respiratory symptoms, particularly in those with preexisting conditions. Occasional Lower Respiratory Infections : Rarely causes bronchitis or bronchiolitis in vulnerable populations. Secondary Infections : This may lead to bacterial sinusitis or otitis media, especially in young children. Rhinovirus is a major cause of the common cold and can exacerbate chronic respiratory issues, especially in the fall and spring seasons. Influenza virus infection causes a systemic cytokine storm by binding to respiratory epithelial cells ( Option B), is incorrect as Influenza, although viral, causes more severe symptoms like high fever, body aches, and fatigue. The patient is not experiencing the intense symptoms flu often brings. Adenovirus infection, binding to cells in the lower respiratory tract, leading to cell damage and high fever (Option C), is incorrect as Adenovirus can also cause respiratory symptoms but typically involves more intense fever and possibly conjunctivitis (eye irritation) . This patient's symptoms do not fit that picture. Streptococcus pneumoniae infection colonizes the throat and releases toxins that cause severe pain and fever (Option D): This is incorrect as this bacterium is behind conditions like pneumonia and sometimes throat infections , but it is much more aggressive. Fever tends to be high, and there would likely be sharp pain or significant chest symptoms, which does not align with this patient’s profile.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 7,
      "question": "A 30-year-old wildlife researcher, who received a full pre-exposure rabies vaccination series two years ago, is bitten by a stray dog in a rural area with known rabies cases. Which of the following is the most appropriate management for this patient? four doses of rabies vaccine on Days 0, 3, 7, and 14. immunity.",
      "options": {
        "A": "Administer a full post-exposure prophylaxis (PEP) series with Rabies Immunoglobulin (RIG) and",
        "B": "Give a booster dose of rabies vaccine on Days 0 and 3, without Rabies Immunoglobulin (RIG).",
        "C": "No additional vaccination or treatment is needed, as the patient completed the pre-exposure series.",
        "D": "Administer a single booster dose of rabies vaccine with Rabies Immunoglobulin (RIG) for rapid"
      },
      "correct_answer": "B",
      "explanation": "Immunoglobulin (RIG). Correct Answer: B) Give a booster dose of rabies vaccine on Days 0 and 3, without Rabies Immunoglobulin (RIG). Explanation: Previously vaccinated individuals require only two booster doses of the rabies vaccine on Days 0 and 3, without RIG. 1. Types of Rabies Vaccines Human Diploid Cell Vaccine (HDCV) Purified Chick Embryo Cell Vaccine (PCECV) Vero Cell Rabies Vaccine (VCRV) (These vaccines are interchangeable and have similar efficacy). 2. Rabies Vaccination Protocols Protocol type Recommended to Schedule Pre-exposure prophylaxis (PrEP) Individuals at higher risk (e.g., veterinarians, animal handlers, travelers to rabies-endemic areas) 3 doses on Day 0 , Day 7 , and Day 21 or 28 Post-exposure prophylaxis (PEP) Individuals exposed to potentially rabid animals (e.g., bites or scratches) Unvaccinated Individuals : 4 doses (Day 0, 3, 7, and 14) with Rabies Immunoglobulin (RIG) administered on Day 0 for immediate passive immunity. Previously Vaccinated Individuals : 2 doses (Day 0 and Day 3), no RIG required 3. Administration Route : Intramuscular injection in the deltoid muscle; thigh for infants. Effectiveness : Near 100% if given promptly and correctly post-exposure. 4. Side Effects Common : Pain at the injection site, mild fever, headache, and muscle soreness. Rare : Severe allergic reactions. 5. Special Considerations Pregnancy : Safe for use if there’s exposure or high risk. Immunocompromised Individuals : May need additional monitoring or doses. Administer a full post-exposure prophylaxis (PEP) series with Rabies Immunoglobulin (RIG) and four doses of rabies vaccine on Days 0, 3, 7, and 14 (Option A) , is incorrect as a full PEP series with RIG is not needed for someone who has completed pre-exposure rabies vaccination. RIG is only required for individuals who have not previously been vaccinated. No additional vaccination or treatment is needed, as the patient completed the pre-exposure series (Option C), which is incorrect as the patient does need additional doses to boost immunity after exposure. Administer a single booster dose of rabies vaccine with Rabies Immunoglobulin (RIG) for rapid immunity (Option D), is incorrect as a single dose is insufficient. Previously vaccinated individuals need two doses (Days 0 and 3) after exposure to ensure adequate immunity. Reference: Sherris & Ryan's Medical Microbiology by Kenneth J. Ryan, 8th Edition, Pages 642 to 644.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 8,
      "question": "Carlos, a 40-year-old father and avid hiker, arrives at the emergency department after being bitten by a stray dog on his forearm while out on a rural trail. The bite is deep enough that it has broken the skin, causing some bleeding. Carlos mentions he's never received a rabies vaccination before and is anxious about the possibility of infection. What is the most appropriate next step in managing Carlos’s injury? Rabies Immunoglobulin (RIG). Immunoglobulin (RIG) around the wound site.",
      "options": {
        "A": "Clean the wound and reassure Carlos that no further treatment is necessary.",
        "B": "Clean the wound and administer a series of rabies vaccines on Days 0, 3, 7, and 14, without giving",
        "C": "Thoroughly wash the wound, administer rabies vaccines on Days 0, 3, 7, and 14, and provide Rabies",
        "D": "Give Carlos a single dose of rabies vaccine and Rabies Immunoglobulin (RIG) for rapid immunity."
      },
      "correct_answer": "C",
      "explanation": "and provide Rabies Immunoglobulin (RIG) around the wound site. Correct Answer: C) Thoroughly wash the wound, administer rabies vaccines on Days 0, 3, 7, and 14, and provide Rabies Immunoglobulin (RIG) around the wound site. Explanation : Carlos’s injury is classified as a Category III exposure because the bite broke the skin and caused bleeding. For Category III exposures, particularly in unvaccinated individuals, treatment requires thorough wound cleaning, a full series of rabies vaccinations, and Rabies Immunoglobulin (RIG) around the wound to provide immediate passive immunity. Categories of dog bite and management: Category Exposure Type Management Category I Touching or feeding animals Licking of intact skin Ensure proper hygiene No treatment required Category II Nibbling on uncovered skin Minor scratches or abrasions without bleeding Immediate wound washing with soap and water Rabies vaccination: Unvaccinated: Days 0, 3, 7, and 14 Previously vaccinated: Booster doses on Days 0 and 3 No Rabies Immunoglobulin (RIG) required Category III Bites or scratches with bleeding Licks on broken skin Exposure to mucous membranes",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmicrobiology/Virology-Picornaviridae_And_Rhabdoviridae_Q8_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 9,
      "question": "Which of the following statements is true regarding the structure and characteristics of the Rabies virus?",
      "options": {
        "A": "Spherical structure and is best visualized by light microscopy.",
        "B": "Single-stranded RNA genome and is best visualized using electron microscopy.",
        "C": "Has a hexagonal structure, observed under a compound microscope.",
        "D": "There are three types of antigens in Rabies"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Single-stranded RNA genome and is best visualized using electron microscopy. family. Its structure is best visualized using electron microscopy due to its small size and unique bullet-like shape. Rabies virus-general features: The Rabies virus belongs to the family Rhabdoviridae and has a characteristic bullet shape, making it unique among many other viruses. Its genome is single-stranded RNA with negative-sense polarity, meaning it cannot directly translate into proteins and requires RNA-dependent RNA polymerase f or replication. The structure of the virus is a helical nucleocapsid (Option C) encased in a lipid envelope with embedded glycoprotein spikes, which play a critical role in binding to host cells and inducing an immune response. Two types of antigens- Glycoprotein G and nucleoprotein are present. (Option D) Due to the small size of viruses, visualization of their structure is best achieved using electron microscopy rather than light microscopy , (Option A) as electron microscopy provides the resolution required to observe such fine structural details. Reference: Ananthanarayan and Paniker’s Textbook of Microbiology, 10th Edition, Page 534",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmicrobiology/Virology-Picornaviridae_And_Rhabdoviridae_Q9_exp.jpg",
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 10,
      "question": "Consider the following statements regarding the Rabies virus and its clinical features. Mark the correct answer. After entry, the Rabies virus travels directly to the bloodstream, where it causes widespread viremia. Rabies virus initially replicates at the site of infection, then travels along peripheral nerves to the central nervous system Spreads retrograde to the CNS. The virus binds to the acetylcholine receptors.",
      "options": {
        "A": "Statement 1 is true.",
        "B": "Statement 2 is false.",
        "C": "Statement 3 is true.",
        "D": "Statement 4 is false."
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Statement 3 is true. Explanation: Rabies virus, a bullet-shaped, negative-sense RNA virus in the Rhabdoviridae family, initially infects muscle cells near the bite site. It binds enters peripheral nerves, traveling retrograde to the CNS. In the brain, it triggers severe encephalitis, causing hydrophobia, agitation, and paralysis, ultimately leading to respiratory failure. Statement 1 is incorrect because the rabies virus does not cause viremia (the presence of the virus in the blood). Instead, it travels via the nervous system to reach the CNS. Therefore ruling out option A. Statement 2 is true. (Option B) Rabies virus enters the body through a bite or scratch from an infected animal. After entry, it initially replicates in muscle cells at the site of infection. The virus then travels along peripheral nerves by retrograde axonal transport to the central nervous system (CNS), where it primarily affects neurons. This neuronal invasion leads to classic clinical manifestations, such as hydrophobia (fear of water), agitation, hallucinations, and, in later stages, paralysis and coma. Statement 4 is true . (Option D )The affinity for acetylcholine receptors contributes to the virus’s neurotropism , or preference for nervous tissue, making Rabies a neuroinvasive pathogen. The presence of these receptors in various neural tissues allows the virus to spread efficiently within the CNS, leading to the extensive neuronal infection seen in Rabies.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 11,
      "question": "Which of the following is the most sensitive and specific test for laboratory diagnosis of rabies?",
      "options": {
        "A": "Viral RNA PCR",
        "B": "Antigen detection",
        "C": "Antibody detection",
        "D": "Virus Isolation"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Viral RNA PCR Explanation: Viral RNA PCR is highly sensitive and specific for diagnosing Rabies in antemortem cases (diagnosing the disease before death), and where sample types like saliva, cerebrospinal fluid (CSF) or skin biopsies are used. Antigen detection (Option B) requires brain tissue and, hence, is not a viable option for diagnosis in living patients (obtaining brain tissue is impractical while a patient is alive), so this limits antigen detection use mainly to post-mortem diagnostics or euthanized animals. Antibody detection (Option C): Rabies antibodies are usually only detectable in the blood or CSF after the infection has progressed to a certain stage, which may be too late for timely intervention in active infections. Antibodies may only appear in the final stages of Rabies or after vaccination (in post-exposure prophylaxis cases). This delay in antibody production makes it a poor choice for early or definitive diagnosis, especially in acute or urgent settings where rapid detection is critical. Virus Isolation (Option D) is very specific yet technically demanding, time-consuming, and less sensitive than PCR. Rabies virus does not grow readily in standard cell culture, so this method is often unsuccessful or requires prolonged incubation. It has a lower sensitivity (may fail to detect low levels of the virus), which PCR can often pick up more reliably and quickly. Reference: Ananthanarayan and Paniker’s Textbook of Microbiology, 10th Edition, Page 534",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    },
    {
      "q_no": 12,
      "question": "In the case of re-exposure to rabies, what is the recommended re-exposure prophylaxis regimen if the initial post-exposure prophylaxis (PEP) was completed 2 months ago?",
      "options": {
        "A": "4 doses on days 0, 3, 7, and 14",
        "B": "3 doses on days 0, 7, and 21",
        "C": "2 doses on days 0 and 3",
        "D": "Wound toilet only, without additional vaccine doses"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Wound toilet only, without additional vaccine doses Explanation: For individuals re-exposed to rabies who previously completed a full PEP course, the recommended re-exposure prophylaxis consists of: Within 3 months of PEP: Wound toilet only done (Option D) After 3 months of PEP (Option C) 2 visits 2 doses Day 0, 3 4 doses on days 0, 3, 7, and 14 (Option A): This regimen describes the standard post-exposure prophylaxis (PEP) for individuals who are receiving rabies vaccination for the first time (unvaccinated individuals). The PEP protocol for unvaccinated individuals typically includes 4 doses of the rabies vaccine administered on days 0, 3, 7, and 14, along with rabies immune globulin (RIG) if indicated. 3 doses on days 0, 7, and 21 (Option B): This regimen is typically used for a primary vaccination series in individuals who have not been vaccinated against rabies (e.g., pre-exposure prophylaxis). In the context of re-exposure prophylaxis after completing a previous PEP course, it is not the recommended approach. Reference: Ananthanarayan and Paniker’s Textbook of Microbiology, 10th Edition, Page 534",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Virology-Picornaviridae And Rhabdoviridae"
    }
  ]
}
